Skip to main content
Equibles

UBS Group AG

Position in EDSA — Edesa Biotech, Inc.

CIK 1610520 ZURICH, V8
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$54,982
+$42,730 QoQ
Shares Held
6,763
+188.6% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 33 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. EDSA ranks #390 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in EDSA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,982 6,763
2026-03-31 $12,252 2,343
2025-12-31 $1,933 1,362
2025-09-30 $4,492 1,819
2025-06-30 $1,386 683
2025-03-31 $9 4
2024-12-31 $51 31
2024-09-30 $17 4
2024-06-30 $17 4
2024-03-31 $16 4
2023-12-31 $19,573 4,283
2023-09-30 $3,423 5,436
2023-06-30 $26 33
2023-03-31 $5,188 5,702
2022-12-31 $71 33
2022-09-30 $30 33
2022-06-30 $1,772 1,101
2022-03-31 $11,963 4,028
2021-12-31 $15,875 2,820
2021-09-30 $39,622 5,369
2021-06-30 $19,953 3,779
2021-03-31 $178 33
2020-12-31 $140 33
2020-09-30 $10,547 1,307
2020-06-30 $15,712 3,200
2020-03-31 $2,214 1,035